Evidence map›Paper›PMID 21606955›Full record

ArticleCell research2011

Coordinate activation of inflammatory gene networks, alveolar destruction and neonatal death in AKNA deficient mice.

Wenbin Ma, Blanca Ortiz-Quintero, Roberto Rangel, Morgan R McKeller, Sara Herrera-Rodriguez, Eliseo F Castillo, Kimberly S Schluns, Mary Hall, Huiyuan Zhang, Woong-Kyung Suh and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. BioMed research international · 2017
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. A HomozygousGenes · 2021
    Article
  7. Article
  8. Article
  9. BioMed research international · 2020
    Article
  10. Genes · 2019
    Article
  11. Article
  12. Article
  13. Hitting the bull's eye: targeting HMGA1 in cancer stem cells.Expert review of anticancer therapy · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Wenbin MaDepartment of Immunology, Unit 902, The University of Texas MD Anderson Cancer Center, 7455 Fannin Street, Houston, TX 77054, USA.
Blanca Ortiz-Quintero
Roberto Rangel
Morgan R McKeller
Sara Herrera-Rodriguez
Eliseo F Castillo
Kimberly S Schluns
Mary Hall
Huiyuan Zhang
Woong-Kyung Suh
Hitoshi Okada
Tak W Mak
Yang Zhou
Michael R Blackburn
Hector Martinez-Valdez
The University of Texas MD Anderson Cancer Center · USThe University of Texas Health Science Center at Houston · USUniversité de Montréal · CAUniversity Health Network · CAUniversity of Toronto · CA

Funding

Training Program in Cancer ImmunobiologyT32CA009598 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ALLISON, JAMES P · 1988 to 2014
$4.9M
Studies of germinal center B cell survivalR01AI065796 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MARTINEZ-VALDEZ, HECTOR · 2005 to 2009
$1.7M
AKNA, germinal center reaction and immunity.R01AI056125 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MARTINEZ-VALDEZ, HECTOR · 2003 to 2007
$1.2M
NCI NIH HHS CA106672NCI NIH HHS T32 CA009598NCI NIH HHS T32 CA009598-15NIAID NIH HHS AI056125-01NIAID NIH HHS AI065796-01NIAID NIH HHS R01 AI056125NIAID NIH HHS R01 AI065796
6 · The paper itself

Abstract

Gene expression can be regulated by chromatin modifiers, transcription factors and proteins that modulate DNA architecture. Among the latter, AT-hook transcription factors have emerged as multifaceted regulators that can activate or repress broad A/T-rich gene networks. Thus, alterations of AT-hook genes could affect the transcription of multiple genes causing global cell dysfunction. Here we report that targeted deletions of mouse AKNA, a hypothetical AT-hook-like transcription factor, sensitize mice to pathogen-induced inflammation and cause sudden neonatal death. Compared with wild-type littermates, AKNA KO mice appeared weak, failed to thrive and most died by postnatal day 10. Systemic inflammation, predominantly in the lungs, was accompanied by enhanced leukocyte infiltration and alveolar destruction. Cytologic, immunohistochemical and molecular analyses revealed CD11b(+)Gr1(+) neutrophils as major tissue infiltrators, neutrophilic granule protein, cathelin-related antimicrobial peptide and S100A8/9 as neutrophil-specific chemoattracting factors, interleukin-1β and interferon-γ as proinflammatory mediators, and matrix metalloprotease 9 as a plausible proteolytic trigger of alveolar damage. AKNA KO bone marrow transplants in wild-type recipients reproduced the severe pathogen-induced reactions and confirmed the involvement of neutrophils in acute inflammation. Moreover, promoter/reporter experiments showed that AKNA could act as a gene repressor. Our results support the concept of coordinated pathway-specific gene regulation functions modulating the intensity of inflammatory responses, reveal neutrophils as prominent mediators of acute inflammation and suggest mechanisms underlying the triggering of acute and potentially fatal immune reactions.

Indexed as

Gene Regulatory NetworksAnimalsAntimicrobial Cationic PeptidesCalgranulin ACalgranulin BCathelicidinsDNA-Binding ProteinsExonsInflammationInterferon-gammaInterleukin-1betaLungMiceMice, Inbred C57BLMice, KnockoutNeutrophilsAKNA protein, humanAntimicrobial Cationic PeptidesCalgranulin ACalgranulin BCathelicidinsDNA-Binding ProteinsInterferon-gammaInterleukin-1betaNuclear ProteinsTranscription Factors

Identifiers

PMID21606955
PMCPMC3365639
OpenAlexW1976914461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.